Loading clinical trials...
Loading clinical trials...
Phase I Safety Study of Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma
Conditions
Interventions
Descartes-11
Fludarabine
+1 more
Locations
2
United States
Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
Medical College of Wisconsin
Madison, Wisconsin, United States
Start Date
August 1, 2019
Primary Completion Date
May 27, 2021
Completion Date
June 11, 2021
Last Updated
May 15, 2025
NCT06152575
NCT06179888
NCT04973605
NCT05201781
NCT06138275
NCT05862012
Lead Sponsor
Cartesian Therapeutics
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions